Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 February 2021 Photo UFS photo archive
The National Control Laboratory for Biological Products (NCL) Building.

There can be no compromise when it comes to the quality of medicines made available to the public.

The UFS-based National Control Laboratory for Biological Products (NCL) is a full member of the international WHO-National Control Laboratory Network for Biologicals and one of 12 laboratories worldwide contracted to perform vaccine testing for the World Health Organisation (WHO). The NCL is also the only vaccine-testing laboratory in the country that performs the final quality-control testing of all human vaccine batches marketed in South Africa on behalf of the South African Health Products Regulatory Authority (SAHPRA).

In its role as a vaccine-testing laboratory for the WHO, the NCL helps to ensure that the vaccines purchased through the WHO prequalification programme for international distribution to resource-limited countries, meet the high standards of quality, safety, and efficiency. 

International testing standards

The laboratory received the status of a pharmaceutical testing laboratory after the South African Accreditation System (SANAS) endorsed its quality-management systems as of a high standard according to the International Standards Organisation’s requirements.

With its international testing standards, the NCL must ensure that all its operations – from the way documents are compiled and stored, to the maintenance of equipment and infrastructure, as well as staff competency – are performed according to international guidelines.

The laboratory has all the quality systems in place to ensure high-quality test results. The certificate of Good Manufacturing Compliance received in 2019 indicates that laboratory testing is on the expected level for any pharmaceutical testing laboratory and manufacturer. This certification is very strict and means that the NCL complies with exceptionally strict standards for pharmaceutical labs anywhere in the world. The certification offers the South African Health Products Regulatory Authority, the WHO, and other national control laboratories around the world the confidence that the test results from the NCL can be trusted.

Licensed as pharmaceutical manufacturer

The laboratory is also licensed as a pharmaceutical manufacturer. Although the lab does not manufacture, it needs to comply with manufacturing standards. It is rare for a pharmaceutical testing laboratory (such as the NCL) outside of a manufacturing context to qualify for both certifications.

News Archive

Prof Britz heading to Yale
2013-04-22

 

Prof Dolf Britz
Photo: Supplied
22 April 2013

Prof Dolf Britz has been awarded the honour of an appointment at Yale Divinity School (YDS) at Yale University in New Haven, Connecticut, in the United States. Starting in August 2013, Prof Britz will be involved in research initiatives and the teaching of post-graduate seminars at the university, which was founded in 1701.
The appointment is the natural progression of a collaboration agreement between the University of the Free State (UFS) and Yale University which dates back to 2009 with the formation of the Jonathan Edwards Centre Africa. The strategic partnership focuses on increasing African access to quality education and is geared towards empowering new-generation African leaders in academic and faith-based organisations with primary scholarly resources, research, education and publication.
Prof Britz’s appointment is equally exciting to the respective faculties involved at the UFS and Yale.
“We are most grateful that the generous support by the University of the Free States makes it possible for Prof Britz to be with us in this capacity,” said Prof Carolyn Sharp, Interim Associate Dean of Academic Affairs at YDS.

Prof Adriaan Neele, the Director of the Jonathan Edwards Center at Yale and extraordinary professor at the UFS, thinks Prof Britz’s appointment can be just as beneficial to YDS students.

“Prof Britz’s keen insight in historical primary sources will be very beneficial to Yale’s students and the faculty. His appointment demonstrates the strategic nature of the academic relationship between the UFS and Yale,” he said.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept